Cargando…

Sertoli-Leydig Cell Tumour and DICER1 Mutation: A Case Report and Review of the Literature

Sertoli-Leydig cell tumours of the ovary (SLCT) are rare tumours predominantly caused by mutations in the DICER1 gene. We present a patient with a unilateral SLCT who had an underlying germline DICER1 gene mutation. We discuss the underlying pathology, risks, and screening opportunities available to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wormald, B., Elorbany, S., Hanson, H., Williams, J. W., Heenan, S., Barton, D. P. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176314/
https://www.ncbi.nlm.nih.gov/pubmed/30356399
http://dx.doi.org/10.1155/2018/7927362
Descripción
Sumario:Sertoli-Leydig cell tumours of the ovary (SLCT) are rare tumours predominantly caused by mutations in the DICER1 gene. We present a patient with a unilateral SLCT who had an underlying germline DICER1 gene mutation. We discuss the underlying pathology, risks, and screening opportunities available to those with a mutation in this gene as SLCT is only one of a multitude of other tumours encompassing DICER1 syndrome. The condition is inherited in an autosomal dominant fashion. As such, genetic counselling is a key component of the management of women with SLCT.